Home › Compare › LYLT vs MRK

LYLT vs MRK: Dividend Comparison 2026

LYLT yields 917.43% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LYLT wins by $8.19355664732259e+22M in total portfolio value
10 years
LYLT
LYLT
● Live price
917.43%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.19355664732259e+22M
Annual income
$81,918,413,245,647,230,000,000,000,000.00
Full LYLT calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — LYLT vs MRK

📍 LYLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLYLTMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LYLT + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LYLT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LYLT
Annual income on $10K today (after 15% tax)
$77,981.65/yr
After 10yr DRIP, annual income (after tax)
$69,630,651,258,800,145,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, LYLT beats the other by $69,630,651,258,800,145,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LYLT + MRK for your $10,000?

LYLT: 50%MRK: 50%
100% MRK50/50100% LYLT
Portfolio after 10yr
$4.096778323661295e+22M
Annual income
$40,959,206,622,823,620,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LYLT
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$2.00
+817.4% upside vs current
Range: $2.00 — $2.00
Altman Z
-0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LYLT buys
0
MRK buys
0
No recent congressional trades found for LYLT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLYLTMRK
Forward yield917.43% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR100% ✓8.2%
Portfolio after 10y$8.19355664732259e+22M$30.7K ✓
Annual income after 10y$81,918,413,245,647,230,000,000,000,000.00 ✓$950.29
Total dividends collected$8.193444388886382e+22M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$2.00$128.54 ✓

Year-by-year: LYLT vs MRK ($10,000, DRIP)

YearLYLT PortfolioLYLT Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$194,186$183,486.24$11,192$351.54+$183.0K → LYLT
2$6,867,686$6,659,907.01$12,524$392.70+$6.86M → LYLT
3$447,605,538$440,257,113.53$14,015$438.65+$447.59M → LYLT
4$54,112,618,693$53,633,680,767.62$15,682$489.96+$54112.60M → LYLT
5$12,177,462,399,201$12,119,561,897,198.88$17,547$547.23+$12177462.38M → LYLT
6$5,110,930,738,675,109$5,097,900,853,907,964.00$19,632$611.16+$5110930738.66M → LYLT
7$4,004,739,394,378,093,600$3,999,270,698,487,711,000.00$21,963$682.53+$4004739394378.07M → LYLT
8$5,861,636,526,069,293,000,000$5,857,351,454,917,308,000,000.00$24,571$762.18+$5861636526069293.00M → LYLT
9$16,031,053,811,830,919,000,000,000$16,024,781,860,748,026,000,000,000.00$27,486$851.08+$16031053811830919168.00M → LYLT
10$81,935,566,473,225,900,000,000,000,000$81,918,413,245,647,230,000,000,000,000.00$30,745$950.29+$8.19355664732259e+22M → LYLT

LYLT vs MRK: Complete Analysis 2026

LYLT — Stock

Loyalty Ventures Inc. provides consumer loyalty solutions. The company owns and operates the AIR MILES Reward Program, an end-to-end loyalty platform; and BrandLoyalty, a campaign-based loyalty solution for grocers and other high-frequency retailers. It also offers marketing, customer, and rewards and redemption management services for sponsors. The company helps financial services providers, retailers, and other consumer-facing businesses to create and increase customer loyalty across various touchpoints. Loyalty Ventures Inc. was incorporated in 2021 and is based in Plano, Texas.

Full LYLT Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this LYLT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LYLT vs SCHDLYLT vs JEPILYLT vs OLYLT vs KOLYLT vs MAINLYLT vs JNJLYLT vs ABBVLYLT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.